215600.KQ
SillaJen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,410.00
−2.23%Margins
Gross margin
-62.4%
EBITDA margin
-227.2%
EBIT margin
-242.7%
Net margin
-223.8%
FCF margin
-191.3%
-23.9%
Return on equity
-22.5%
Return on assets
-25.6%
Return on invested capital
0.10x
Asset turnover
-KRW 20.5B
Cash from operations
KRW 493
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026